The potential role of bevacizumab in early stages and locally advanced non-small cell lung cancer

Improving outcomes for early-stage non-small cell lung cancer (NSCLC) is a major research area considering that a significant percentage of such patients develop recurrent disease within 5 years of complete lung resection. Adjuvant chemotherapy prolongs survival, with an absolute improvement in 5-ye...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Schettino, Clorinda, Bareschino, Maria Anna, Rossi, Antonio, Maione, Paolo, Castaldo, Vincenzo, Mazzeo, Nicole, Sacco, Paola Claudia, Ferrara, Marianna Luciana, Palazzolo, Giovanni, Ciardiello, Fortunato, Gridelli, Cesare
Formato: Artigo
Idioma:Inglês
Publicado: SAGE Publications 2009
Assuntos:
Reviews
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3125989/
https://ncbi.nlm.nih.gov/pubmed/21789109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834009338635
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares